pumitepa has been researched along with Abnormalities, Autosome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lazutka, JR; Slapsyte, G | 1 |
| Jarmalaite, S; Lazutka, JR; Lekevicius, RK; Slapsyte, G | 1 |
| Lazutka, IuS; Lekiavichius, RK; Slapshite, GV | 1 |
3 other study(ies) available for pumitepa and Abnormalities, Autosome
| Article | Year |
|---|---|
Persistence of cytogenetic damage induced by alkylating antineoplastic drug phopurinum in human lymphocytes in vivo and in vitro.
Topics: Antineoplastic Agents; Aziridines; Chromosome Aberrations; DNA Damage; Dose-Response Relationship, Drug; Female; Humans; Lymphocytes; Metaphase; Middle Aged; Organophosphorus Compounds; Ovarian Neoplasms; Purines; Regression Analysis; Sister Chromatid Exchange | 1990 |
In vitro interaction between two antineoplastic drugs--phopurinum and interferon alpha 2.
Topics: Adult; Antineoplastic Agents; Aziridines; Chromosome Aberrations; Drug Interactions; Female; Humans; Interferon Type I; Organophosphorus Compounds; Purines; Recombinant Proteins; Sister Chromatid Exchange | 1989 |
[Effect of natural human leukocyte interferon on cell cycle kinetics, the frequency of sister chromatid exchanges and chromosome aberrations in fopurin-treated human lymphocytes].
Topics: Antineoplastic Agents; Aziridines; Azirines; Cell Cycle; Cells, Cultured; Chromosome Aberrations; Dose-Response Relationship, Drug; Drug Interactions; Humans; Interferon Type I; Lymphocytes; Mathematics; Purines; Sister Chromatid Exchange | 1989 |